Faculty Opinions recommendation of Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1165518.628516 ◽

2009 ◽

Author(s):

Reto Nüesch

Keyword(s):

Interim Analysis ◽

Controlled Trial ◽

Cholera Vaccine ◽

Efficacy And Safety ◽

Double Blind ◽

Whole Cell ◽

Double Blind Placebo ◽

Cluster Randomised ◽

Oral Cholera Vaccine

Download Full-text

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(09)61297-6 ◽

2009 ◽

Vol 374 (9702) ◽

pp. 1694-1702 ◽

Cited By ~ 171

Author(s):

Dipika Sur ◽

Anna Lena Lopez ◽

Suman Kanungo ◽

Allison Paisley ◽

Byomkesh Manna ◽

...

Keyword(s):

Interim Analysis ◽

Controlled Trial ◽

Cholera Vaccine ◽

Efficacy And Safety ◽

Double Blind ◽

Whole Cell ◽

Double Blind Placebo ◽

Cluster Randomised ◽

Oral Cholera Vaccine

Download Full-text

Faculty Opinions recommendation of 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718167125.793487644 ◽

2013 ◽

Author(s):

Carlos Seas

Keyword(s):

Controlled Trial ◽

Cholera Vaccine ◽

Double Blind ◽

Whole Cell ◽

Double Blind Placebo ◽

Cluster Randomised ◽

Oral Cholera Vaccine

Download Full-text

Faculty Opinions recommendation of 5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718167125.793488075 ◽

2013 ◽

Author(s):

Richard Pollok

Keyword(s):

Controlled Trial ◽

Cholera Vaccine ◽

Double Blind ◽

Whole Cell ◽

Double Blind Placebo ◽

Cluster Randomised ◽

Oral Cholera Vaccine

Download Full-text

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(13)70273-1 ◽

2013 ◽

Vol 13 (12) ◽

pp. 1050-1056 ◽

Cited By ~ 140

Author(s):

Sujit K Bhattacharya ◽

Dipika Sur ◽

Mohammad Ali ◽

Suman Kanungo ◽

Young Ae You ◽

...

Keyword(s):

Controlled Trial ◽

Cholera Vaccine ◽

Double Blind ◽

Whole Cell ◽

Double Blind Placebo ◽

Cluster Randomised ◽

Oral Cholera Vaccine

Download Full-text

Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults

Vaccine ◽

10.1016/0264-410x(90)90012-b ◽

1990 ◽

Vol 8 (6) ◽

pp. 577-580 ◽

Cited By ~ 52

Author(s):

S.J. Cryz ◽

M.M. Levine ◽

J.B. Kaper ◽

E. Fürer ◽

B. Althaus

Keyword(s):

Vaccine Strain ◽

Controlled Trial ◽

Cholera Vaccine ◽

Double Blind ◽

Double Blind Placebo ◽

Oral Cholera Vaccine

Download Full-text

Randomized, double-blind, placebo-controlled trial to evaluate the safety and immunogenicity of live oral cholera vaccine 638 in Cuban adults

Vaccine ◽

10.1016/j.vaccine.2009.08.042 ◽

2009 ◽

Vol 27 (47) ◽

pp. 6564-6569 ◽

Cited By ~ 13

Author(s):

Rodrigo Valera ◽

Hilda María García ◽

Manuel Díaz Jidy ◽

Mayelin Mirabal ◽

Marlene Isabel Armesto ◽

...

Keyword(s):

Controlled Trial ◽

Cholera Vaccine ◽

Double Blind ◽

Double Blind Placebo ◽

Oral Cholera Vaccine

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1088945.542078 ◽

2007 ◽

Author(s):

Jonathan Schapiro

Keyword(s):

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108987.566149 ◽

2008 ◽

Author(s):

Johann Gudjonsson

Keyword(s):

Monoclonal Antibody ◽

Controlled Trial ◽

Interleukin 12 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958672.793516776 ◽

2016 ◽

Author(s):

Robin Spiller

Keyword(s):

Irritable Bowel Syndrome ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Irritable Bowel

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718524881.793498396 ◽

2014 ◽

Author(s):

David Daikh

Keyword(s):

Ankylosing Spondylitis ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text